MedTrace Logo

Comparability of Bispectral Index and NeuroSENSE in Aged Patients

NCT02015741 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-10-31

No results posted yet for this study

Summary

The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA).

Use of such devices is discussed in aged patients. The purpose of this study is to compare Bispectral Index and NeuroSENSE during awake periods and during natural sleep.

Conditions

  • Sleep

Interventions

DEVICE

EEG monitoring with Bispectral Index and NeuroSENSE

BEHAVIORAL

Clinical observation

Patients will be observed during awake periods and during natural sleep.

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Julie Bresson, MD · Hopital Foch

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02015741 on ClinicalTrials.gov